Our mission: supporting the vaccine community with adjuvant and formulation expertise on an open access basis

Adjuvants are key components of modern vaccines, because of – among others – their ability to modulate immune responses, enable dose-sparing and improve efficacy of numerous life-saving vaccines. 

However, suitable adjuvants and the associated expertise required to effectively use them are not always openly available to the majority of vaccine researchers and developers.

VFI, a not-for-profit company based in Switzerland, is dedicated to provide its technologies in open-access to all interested groups.

Since 2012, VFI provides vaccine researchers and developers a variety of adjuvant-related laboratory and training activities. This includes advise on how to correctly formulate and characterize the adjuvants and the resulting vaccine formulations. 

Our main activities